infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Infertile patients undergoing FET, with previous transplantation cycles =2; 2) age: 21= age < 38; 3) at least one high-quality blastocyst or two high-quality cleavage embryos; 4) patients with hormone replacement cycle for endometrial preparation; 5) hysteroscopy examination was completed and the results were normal; 6) voluntarily sign informed consent; Note: Patients who met the above 6 criteria were included in this study.
Exclusion criteria
Exclusion criteria: 1) Those planning to undergo pre-implantation genetic testing (PGT); 2) Patients with uterine abnormalities (unicornuate uterus, bicornuate uterus, didelphic uterus, or untreated uterine septum) or other untreated diseases damaging the uterine cavity, such as adenomyosis, submucosal fibroids, uterine adhesions, or scarred uterus; 3) Those with uncorrected hyperprolactinemia, hyperandrogenism, thyroid dysfunction, or chronic adrenal insufficiency and other metabolic endocrine diseases; 4) Those with recurrent miscarriage; 5) Those with a tendency for bleeding or easy infection, severe allergies, or contraindications such as ulcers, and scars, and those prohibited from acupuncture; 6) patients who received acupuncture treatment in the past three months; 7) patients who are participating in other clinical trials. Note: Patients meeting any of the above criteria should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cycle cancellation rate;Biochemical pregnancy rate;Embryo implantation rate;Live birth rate; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine; Sichuan Jinxin Xinan Women's and Children's Hospital